A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model

Pre-clinical models mimicking persistent hepatitis B virus (HBV) expression are seldom, do not capture all features of a human chronic infection and due to their complexity, are subject to variability. We report a meta-analysis of seven experiments performed with TG1050, an HBV-targeted immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kratzer, Roland, Sansas, Benoît, Lélu, Karine, Evlachev, Alexei, Schmitt, Doris, Silvestre, Nathalie, Inchauspé, Geneviève, Martin, Perrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037470/
https://www.ncbi.nlm.nih.gov/pubmed/29388874
http://dx.doi.org/10.1080/21645515.2018.1433970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037470/
https://www.ncbi.nlm.nih.gov/pubmed/29388874
http://dx.doi.org/10.1080/21645515.2018.1433970

Ejemplares similares